ArtNr |
PRS-3561-0.1mg |
Hersteller |
ProSci
|
Menge |
0.1 mg |
Kategorie |
|
Typ |
Antibody Polyclonal |
Format |
Liquid |
Applikationen |
WB, ELISA |
Specific against |
Human, Mouse |
Host |
Rabbit |
ECLASS 10.1 |
32160702 |
ECLASS 11.0 |
32160702 |
UNSPSC |
12352203 |
Alias |
CTRP2 Antibody: CTRP2, zacrp2, CTRP2, UNQ6349/PRO21054, Complement C1q tumor necrosis factor-related protein 2 |
Lieferbar |
|
Shipping |
blue ice or RT |
By Research Area |
Chemokines & Cytokines, Signal Transduction |
Immunogen |
CTRP2 antibody was raised against a 16 amino acid synthetic peptide from near the amino-terminus of human CTRP2.
The immunogen is located within amino acids 50 - 100 of CTRP2. |
Applications |
CTRP2 antibody can be used for the detection of CTRP2 by Western blot at 1 μ g/mL.
Antibody validated: Western Blot in human samples. All other applications and species not yet tested. |
Specificity |
These proteins are often highly modified post-translationally and migrate in SDS-PAGE at positions other than their predicted size. |
Positive Control 1 |
Cat. No. 1223 - Caco-2 Cell Lysate |
Purification |
CTRP2 Antibody is affinity chromatography purified via peptide column. |
Clonality |
Polyclonal |
Isotype |
IgG |
Conjugate |
Unconjugated |
Buffer |
CTRP2 Antibody is supplied in PBS containing 0.02% sodium azide. |
Concentration |
1 mg/mL |
Storage Conditions |
CTRP2 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. |
Related Products |
Cat. No. 3561P – CTRP2 Peptide |
Disclaimer |
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only. |
Modifications |
None |
Ncbi Official Symbol |
C1QTNF2 |
Accession # |
NP_114114 |
Protein Gi # |
94818738 |
Ncbi Gene Id # |
114898 |
User Note |
Optimal dilutions for each application to be determined by the researcher. |
Ncbi Official Symbol |
C1QTNF2 |
Ncbi Official Full Name |
C1q and tumor necrosis factor related protein 2 |
Ncbi Organism |
Homo sapiens |
Swissprot # |
Q9BXJ5 |
Background |
CTRP2 Antibody: Adipose tissue of an organism plays a major role in regulating physiologic and pathologic processes such as metabolism and immunity by producing and secreting a variety of bioactive molecules termed adipokines. One highly conserved family of adipokines is adiponectin/ACRP30 and its structural and functional paralogs, the C1q/tumor necrosis factor-alpha-related proteins (CTRPs) 1-7. Unlike adiponectin, which is expressed exclusively by differentiated adipocytes, the CTRPs are expressed in a wide variety of tissues. These proteins are thought to act mainly on liver and muscle tissue to control glucose and lipid metabolism. An analysis of the crystal structure of adiponectin revealed a structural and evolutionary link between TNF and C1q-containing proteins, suggesting that these proteins arose from a common ancestral innate immunity gene. Of the CTRPs, CTRP2 is most similar structurally and functionally to adiponectin. Recombinant CTRP2 rapidly activated AMPK and MAPK in cultured C2C12 cells, leading to increased glycogen accumulation and fatty acid oxidation. |
Background References 1 |
Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 2005; 115:911-9. |
Background References 2 |
Tsao T-S, Lodish HF, and Fruebis J. ACRP30, a new hormone controlling fat and glucose metabolism. Euro. J. Pharmacol. 2002; 440:213-21. |
Background References 3 |
Wong GW, Wang J, Hug C, et al. A family of Acrp30/ adiponectin structural and functional paralogs. Proc. Natl. Acad. Sci. USA 2004; 101:10302-7. |
Background References 4 |
Shapiro L and Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr. Biol. 1998; 8:335-8. |
1st Image Caption |
Western blot analysis of CTRP2 in Caco-2 cell lysate with CTRP2 antibody at 1 μ g/mL in either the (A) absence or (B) presence of blocking peptide. |
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.